Evidence brief: Supporting self-management of MA from pharmacies

Self-managed health   |   28 September 2020 



This MSI evidence brief summarises the recent learnings and practices that can help to create an enabling environment for the safe, supported self-management of medication abortion (MA) from pharmacies, an increasing pathway to care due to the COVID-19 pandemic.

With contributions from Ipas, IPPF, DKT and Options, this brief provides key recommendations for ensuring users of MA have access to information on how to safely self-manage MA products purchased from pharmacies and seek follow up care when needed.

This consolidation of evidence highlights the importance of interventions such as pictorial instructions, contact centres, websites and digital media, and the ways that information to pharmacy clients can be strengthened through community engagement. The brief also found that product labelling can be confusing and hard to decipher for low-literacy clients, and that hotlines and other digital platforms are essential for providing interactive responses to clients.

The briefing also includes links to existing resources that can support implementers.



Related posts


28 September 2020

Briefing: Choice on the Ballot

2024 is the biggest election year in history and reproductive rights hang in the balance.


28 September 2020   |   2 min read

Every Stage of Woman: Providing Advice and Care throughout women’s lives

Expanding MSI clinical offerings to ensure women feel supported and cared for from menstruation to menopause.


28 September 2020

How we’re engaging community leaders to expand access to reproductive choice

Insights from MSI’s work with community leaders in West Africa.